Form 483 · FEI 3009713694

Form 483 issued June 23, 2023 · Toledo, Spain

Inspection
Jun 15 – Jun 23, 2023
Observations
7
Pages
17
FEI number
3009713694

In short: On June 23, 2023, FDA issued a Form 483 with 7 observations to an FDA-inspected site in Toledo, Spain (FEI 3009713694) after an inspection that ran Jun 15 – Jun 23, 2023. The investigators were Pratik S. Upadhyay and Xiaokuang Lai. Most observations concern quality system and laboratory controls.

At a glance

Quality system and laboratory controls account for 6 of 7 observations.

Quality system3
Laboratory controls3
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

  2. 02

    Written records of investigation of a drug complaint do not include the…

  3. 03

    Procedures designed to prevent microbiological contamination of drug products purporting to be…

  4. 04

    Laboratory records do not include complete data derived from all tests, examinations and assay necessary to…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at an FDA-inspected site?

FDA listed 7 observations on this Form 483, mostly about quality system, laboratory controls and production. The opening words of each observation are shown on this page.

Who inspected an FDA-inspected site?

Pratik S. Upadhyay and Xiaokuang Lai are named on this Form 483, for the inspection of Jun 15 – Jun 23, 2023. Each investigator has a profile showing what they cite most.

When was an FDA-inspected site inspected by FDA?

The inspection ran Jun 15 – Jun 23, 2023, and the Form 483 is dated June 23, 2023.

How do I get the full Form 483 for an FDA-inspected site?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free